Abstract
Purpose
Small, abnormal parathyroid glands are usually associated with multigland hyperplasia in patients with primary hyperparathyroidism (pHPT). The purpose of this study was to determine the association between parathyroid adenoma size and biochemical cure rates in patients undergoing single gland parathyroidectomy.
Methods
The study included patients with sporadic pHPT who underwent initial parathyroidectomy and met intraoperative PTH criteria for cure after resection of a single adenoma (SGD). Patients were divided into quartiles (Q1 = smallest) based on gland weight and maximum dimension; cure rates were compared across groups.
Results
A single parathyroid adenoma was removed in 517 patients, with a median gland weight of 500 mg (range 50–11890). Median maximum gland dimension was 15 mm (range 5–55). With median follow-up of 28 months (range 6–81), the biochemical cure rate was 97.1%. There was no difference in cure rate by gland weight (Q1 94.6%, Q2 96.9%, Q3 98.4%, Q4 98.5%, p = 0.217) or maximum gland dimension (Q1 95.6%, Q2 97.6%, Q3 97.1%, Q4 98.2%, p = 0.641). When Q1 patients (by gland weight) were divided by quartile, there was no difference in cure rates (93.1% [50–140 mg]; 95.2% [150–190 mg]; 97.1% [200–230 mg]; 93.3% [240–280 mg]; p = 0.665).
Conclusion
For patients with pHPT who underwent single gland parathyroidectomy, there was no difference in cure rates by gland weight or maximum dimension. These data suggest that the removal of parathyroid adenomas as small as 50 mg with an appropriate decline in ioPTH likely represent single gland disease and additional exploration may not be necessary.
Similar content being viewed by others
References
Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569. https://doi.org/10.1210/jc.2014-1413
Mak N, Li J, Vasilyeva E et al (2020) Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: when should you end the operation? Am J Surg. https://doi.org/10.1016/j.amjsurg.2020.02.049
Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 151(10):959–968. https://doi.org/10.1001/jamasurg.2016.2310
Kunstman JW, Udelsman R (2012) Superiority of minimally invasive parathyroidectomy. Adv Surg 46:171–189. https://doi.org/10.1016/j.yasu.2012.04.004
Laird AM, Libutti SK (2016) Minimally invasive parathyroidectomy versus bilateral neck exploration for primary hyperparathyroidism. Surg Oncol Clin N Am 25(1):103–118. https://doi.org/10.1016/j.soc.2015.08.012
Walsh NJ, Sullivan BT, Duke WS, Terris DJ (2019) Routine bilateral neck exploration and four-gland dissection remains unnecessary in modern parathyroid surgery. Laryngoscope Investig Otolaryngol 4(1):188–192. https://doi.org/10.1002/lio2.223
Schneider DF, Mazeh H, Sippel RS, Chen H (2012) Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. Surgery. 152(6):1008–1015. https://doi.org/10.1016/j.surg.2012.08.022
Norman J, Lopez J, Politz D (2012) Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg 214(3):260–269. https://doi.org/10.1016/j.jamcollsurg.2011.12.007
Lappas D, Noussios G, Anagnostis P, Adamidou F, Chatzigeorgiou A, Skandalakis P (2012) Location, number and morphology of parathyroid glands: results from a large anatomical series. Anat Sci Int 87(3):160–164. https://doi.org/10.1007/s12565-012-0142-1
Wang C (1976) The anatomic basis of parathyroid surgery. Ann Surg 183(3):271–275. https://doi.org/10.1097/00000658-197603000-00010
Gilmour JR, Martin WJ (1937) The weight of the parathyroid glands. J Pathol Bacteriol 44(2):431–462. https://doi.org/10.1002/path.1700440218
Akerstrom G, Grimelius L, Johansson H, Lundqvist H, Pertoft H, Bergstrom R (1981) The parenchymal cell mass in normal human parathyroid glands. Acta Pathol Microbiol Scand A 89(5):367–375. https://doi.org/10.1111/j.1699-0463.1981.tb00234.x
Khokar AM, Kuchta KM, Moo-Young TA, Winchester DJ, Prinz RA (2020) Increasing trend of bilateral neck exploration in primary hyperparathyroidism. Am J Surg 219(3):466–470. https://doi.org/10.1016/j.amjsurg.2019.09.039
Mazotas IG, Yen TWF, Doffek K et al (2020) Persistent/recurrent primary hyperparathyroidism: does the number of abnormal glands play a role? J Surg Res 246:335–341. https://doi.org/10.1016/j.jss.2019.08.007
Norlen O, Glover A, Zaidi N et al (2015) The weight of the resected gland predicts rate of success after image-guided focused parathyroidectomy. World J Surg 39(8):1922–1927. https://doi.org/10.1007/s00268-015-3017-5
McHenry CR, Shi HH (2018) Can parathyroid hyperplasia be predicted preoperatively? Am J Surg 215(3):389–392. https://doi.org/10.1016/j.amjsurg.2017.10.051
McCoy KL, Chen NH, Armstrong MJ et al (2014) The small abnormal parathyroid gland is increasingly common and heralds operative complexity. World J Surg 38(6):1274–1281. https://doi.org/10.1007/s00268-014-2450-1
Glenn JA, Yen TW, Javorsky BR et al (2016) Association between body mass index and multigland primary hyperparathyroidism. J Surg Res 202(1):132–138. https://doi.org/10.1016/j.jss.2015.12.055
Carsello CB, Yen TW, Wang TS (2012) Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter? Surgery. 152(4):575–581; discussion 581-3. https://doi.org/10.1016/j.surg.2012.07.005
Amin AL, Wang TS, Wade TJ et al (2011) Nonlocalizing imaging studies for hyperparathyroidism: where to explore first? J Am Coll Surg 213(6):793–799. https://doi.org/10.1016/j.jamcollsurg.2011.09.011
Carr AA, Yen TW, Wilson SD, Evans DB, Wang TS (2017) Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making. J Surg Res 209:162–167. https://doi.org/10.1016/j.jss.2016.10.006
Leiker AJ, Yen TW, Eastwood DC et al (2013) Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed. JAMA Surg 148(7):602–606. https://doi.org/10.1001/jamasurg.2013.104
Khan ZF, Lew JI (2019) Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism. Endocrinol Metab (Seoul) 34(4):327–339. https://doi.org/10.3803/EnM.2019.34.4.327
Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W (2009) Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbeck's Arch Surg 394(5):843–849. https://doi.org/10.1007/s00423-009-0510-z
Coan KE, Yen TWF, Carr AA et al (2016) Intraoperative ex vivo parathyroid aspiration: a point-of-care test to confirm parathyroid tissue. Surgery. 160(4):850–857. https://doi.org/10.1016/j.surg.2016.06.036
O'Sullivan K, Yen TWF, Doffek K et al (2021) An Institutional experience with primary hyperparathyroidism in the elderly over two decades. Am J Surg. https://doi.org/10.1016/j.amjsurg.2021.01.027
Author information
Authors and Affiliations
Contributions
Sophie Dream: study design, database preparation, statistical analysis, and manuscript preparation. Tina WF Yen: study design, database preparation, and manuscript revision. Kara Doffek: study design and database preparation. Douglas B. Evans: study design and manuscript revision. Tracy S. Wang: study design, database preparation, and manuscript revision.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Medical College of Wisconsin Institutional Review Board with waiver of informed consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dream, S., Yen, T.W.F., Doffek, K. et al. Variation in parathyroid adenoma size in patients with sporadic, primary hyperparathyroidism: small gland size does not preclude single gland disease. Langenbecks Arch Surg 407, 2067–2073 (2022). https://doi.org/10.1007/s00423-022-02539-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-022-02539-z